ArticleThe European respiratory journal2024
FEV
Article in The European respiratory journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Physiological quotients and mortality: redefining lung function interpretation beyond FEVThe European respiratory journal · 2026Article
- Joint statement from GOLD/GLI regarding the use of spirometry to define airflow obstruction and diagnose COPD.The European respiratory journal · 2026Article
- PeakExperimental physiology · 2026Article
- Challenges and the Future of Pulmonary Function Testing in Chronic Obstructive Pulmonary Disease (COPD): Toward Earlier Diagnosis of COPD.Tuberculosis and respiratory diseases · 2025Article
- An updated comparison of standard and novel FEV1 indices' association with all-cause mortality.PloS one · 2025Article
- A narrative review on lung injury: mechanisms, biomarkers, and monitoring.Critical care (London, England) · 2024Review
- Reply to Miller: Race-Specific Interpretation of Spirometry.Annals of the American Thoracic Society · 2024Article
- ERS/ATS Global Lung Function Initiative normal values and classifying severity based on z-scores instead of per cent predicted.Breathe (Sheffield, England) · 2024Article
- Race-Specific Interpretation of Spirometry.Annals of the American Thoracic Society · 2024Article
- Testing the Limits: Alternative Definitions of Spirometry Thresholds.Annals of the American Thoracic Society · 2024Article
- Framing the Consequences of Implementing Race-Neutral Interpretation of Spirometry.Annals of the American Thoracic Society · 2024Article
- Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children: Time for a Rethink?Transplantation and cellular therapy · 2024Review
Corrections and comments
- Commented on byFEV2024
Authors and funding
5 authors.
Funding
Abstract
backgroundForced expiratory volume in 1 s quotient (FEV
methodsWhite and Black adults with complete spirometry and mortality data from the National Health and Nutrition Examination Survey (NHANES) III and the United Network for Organ Sharing (UNOS) database for lung transplant referrals were included. FEV
resultsAmong 7182 individuals from NHANES III and 7149 from UNOS, 1907 (27%) and 991 (14%), respectively, were Black. The lower boundary FEV
conclusionsFEV
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.